María Jesús Lucero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
María Jesús Lucero has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Ma Rosa Jiménez-Castellanos
Dpto. Farmacia y Tecnología Farmacéutica, Universidad de Sevilla, Sevilla, Spain
7 shared publications Carmen Claro
4 shared publications- Marta Casas
Department of Pharmacy and Pharmaceutical Technology, University of Seville, 41012 Seville, Spain
4 shared publications J. Vigo
Departamento de Farmacia y Tecnologia Farmacéutica, Facultad de Farmacia, Universidad de Sevilla, C/ Profesor Garcia González, s/n, 41012 Sevilla, Spain
3 shared publications- Luis Fernando López Cortés
Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, Spanish National Research Council (CSIC), University of Seville, Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Seville, Spain
3 shared publications - C. Ferris
Dpto. Química Orgánica y Farmacéutica, Facultad de Farmacia, Universidad de Sevilla, Prof. García González no. 2, 41012 Sevilla, Spain
2 shared publications
Latest Publications
- 7 April 2017
- Published by Wiley in European Journal of Lipid Science and Technology
- Vol. 119 (9)
Influence of refining processes on content of bioactive compounds, rheology, and texture of olive pomace oil for use in topical formulations
Retaining the bioactive ingredients of olive pomace oil is a crucial step in ensuring their functional or pharmaceutical value. To help select the best method for retaining bioactive compounds in olive pomace oil, three refining processes, namely, chemical, classical physical, or molecular distillation, were compared at different temperatures. For each method, the contents of triacylglycerols, fatty acids (oleic acid, linoleic, and linolenic acids), triterpenic acids (oleanolic and maslinic acids), and unsaponifiable matter (squalene, aliphatic, sterols, and terpenic) were studied. We observed that physical refining by molecular distillation provided oils with interesting amounts of bioactive compounds, especially triterpenic acids. Of these oils, the samples submitted to a temperature of 190°C exhibited a greater albeit low acidity compared with the other oils obtained by chemical and classical physical refining but exhibited higher amounts of all bioactive compounds. Conversely, the molecular distillation refining process had only a slight effect on the values of the consistency index. The firmness, cohesiveness, and adhesiveness parameters from texture profile analysis indicated that in general, all deodorized oils had high smoothness and spreadability but low adhesiveness. Molecular distillation was concluded to be the best refining process. Nevertheless, it is necessary to improve the working conditions of this process.Practical applications: Olive pomace oil has all functional compounds of extra virgin olive oil, but with a higher concentration of some minor components. It is, therefore, very interesting to use it in skin care formulations. However, for use in the pharmaceutical field must be refined. This study aimed to provide determine the influence of different refining processes (chemical refining, classical physical refining, or physical refining by molecular distillation at different temperatures) in determining the composition of bioactive compounds. The best refining process was selected based on the analytical determination of bioactive compounds by gas chromatography. Results indicated that molecular distillation is the best refining process. Nevertheless, it is necessary to improve the working conditions.Scheme of the extraction and refining processes to which olive pomace oil is subjected, to achieve the lowest losses of bioactive compounds for use in topical formulations.
- 7 April 2017
- Published by Wiley in European Journal of Lipid Science and Technology
- Vol. 119 (9)
Influence of refining processes on content of bioactive compounds, rheology, and texture of olive pomace oil for use in topical formulations
Retaining the bioactive ingredients of olive pomace oil is a crucial step in ensuring their functional or pharmaceutical value. To help select the best method for retaining bioactive compounds in olive pomace oil, three refining processes, namely, chemical, classical physical, or molecular distillation, were compared at different temperatures. For each method, the contents of triacylglycerols, fatty acids (oleic acid, linoleic, and linolenic acids), triterpenic acids (oleanolic and maslinic acids), and unsaponifiable matter (squalene, aliphatic, sterols, and terpenic) were studied. We observed that physical refining by molecular distillation provided oils with interesting amounts of bioactive compounds, especially triterpenic acids. Of these oils, the samples submitted to a temperature of 190°C exhibited a greater albeit low acidity compared with the other oils obtained by chemical and classical physical refining but exhibited higher amounts of all bioactive compounds. Conversely, the molecular distillation refining process had only a slight effect on the values of the consistency index. The firmness, cohesiveness, and adhesiveness parameters from texture profile analysis indicated that in general, all deodorized oils had high smoothness and spreadability but low adhesiveness. Molecular distillation was concluded to be the best refining process. Nevertheless, it is necessary to improve the working conditions of this process.Practical applications: Olive pomace oil has all functional compounds of extra virgin olive oil, but with a higher concentration of some minor components. It is, therefore, very interesting to use it in skin care formulations. However, for use in the pharmaceutical field must be refined. This study aimed to provide determine the influence of different refining processes (chemical refining, classical physical refining, or physical refining by molecular distillation at different temperatures) in determining the composition of bioactive compounds. The best refining process was selected based on the analytical determination of bioactive compounds by gas chromatography. Results indicated that molecular distillation is the best refining process. Nevertheless, it is necessary to improve the working conditions.Scheme of the extraction and refining processes to which olive pomace oil is subjected, to achieve the lowest losses of bioactive compounds for use in topical formulations.
- 1 October 2016
- Published by Elsevier in Carbohydrate Polymers
- Vol. 151, 692-699
Novel aqueous chitosan-based dispersions as efficient drug delivery systems for topical use. Rheological, textural and release studies
- 1 October 2016
- Published by Elsevier in Carbohydrate Polymers
- Vol. 151, 692-699
Novel aqueous chitosan-based dispersions as efficient drug delivery systems for topical use. Rheological, textural and release studies
- 1 October 2014
- Published by Elsevier in Carbohydrate Polymers
- Vol. 111, 125-132
Synthesis and characterization of a novel chitosan-N-acetyl-homocysteine thiolactone polymer using MES buffer
- 1 October 2014
- Published by Elsevier in Carbohydrate Polymers
- Vol. 111, 125-132
Synthesis and characterization of a novel chitosan-N-acetyl-homocysteine thiolactone polymer using MES buffer
- 18 August 2014
- Published by Wiley in European Journal of Lipid Science and Technology
- Vol. 117 (1) , 87-91
Physico‐chemical and rheological characterization of olive‐pomace oils
In this paper the characteristics and rheological behavior of crude olive‐pomace oil extracted by mechanical and chemical means throughout one harvest period have been studied. Oils were turbid at 25°C and behaved as non‐Newtonian fluids. While the mechanically extracted samples fitted to the rheological model of Herschel–Bulkley, the chemical extracted samples fitted better to the model of Ostwald‐De Waele or Power Law.The mechanical properties of the olive‐pomace oils have been studied from rotational rheological point of view in order to obtain information about the flow behavior and the viscosity, necessary in different fields of application for the design, development, optimization, and quality control of new formulations with this type of oil.
- 18 August 2014
- Published by Wiley in European Journal of Lipid Science and Technology
- Vol. 117 (1) , 87-91
Physico‐chemical and rheological characterization of olive‐pomace oils
In this paper the characteristics and rheological behavior of crude olive‐pomace oil extracted by mechanical and chemical means throughout one harvest period have been studied. Oils were turbid at 25°C and behaved as non‐Newtonian fluids. While the mechanically extracted samples fitted to the rheological model of Herschel–Bulkley, the chemical extracted samples fitted better to the model of Ostwald‐De Waele or Power Law.The mechanical properties of the olive‐pomace oils have been studied from rotational rheological point of view in order to obtain information about the flow behavior and the viscosity, necessary in different fields of application for the design, development, optimization, and quality control of new formulations with this type of oil.
- 1 January 2013
- Published by Elsevier in Carbohydrate Polymers
- Vol. 92 (1) , 149-156
Drug diffusion from disperse systems with a hydrophobically modified polysaccharide: Enhancer® vs Franz cells
- 1 January 2013
- Published by Elsevier in Carbohydrate Polymers
- Vol. 92 (1) , 149-156
Drug diffusion from disperse systems with a hydrophobically modified polysaccharide: Enhancer® vs Franz cells
- 1 August 2011
- Published by Elsevier in Carbohydrate Polymers
- Vol. 86 (2) , 891-896
Rheological and mechanical properties of hydrophilic dispersions using a new hydrophobically modified polymer and Igepal® CO520
- 1 August 2011
- Published by Elsevier in Carbohydrate Polymers
- Vol. 86 (2) , 891-896
Rheological and mechanical properties of hydrophilic dispersions using a new hydrophobically modified polymer and Igepal® CO520
- 1 March 2009
- Published by Elsevier in Experimental Eye Research
- Vol. 88 (3) , 528-534
Determination and pharmacokinetic profile of liposomal foscarnet in rabbit ocular tissues after intravitreal administration
- 1 March 2009
- Published by Elsevier in Experimental Eye Research
- Vol. 88 (3) , 528-534
Determination and pharmacokinetic profile of liposomal foscarnet in rabbit ocular tissues after intravitreal administration
- 1 January 2008
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 347 (1-2) , 45-53
Surface tension and rheology of aqueous dispersed systems containing a new hydrophobically modified polymer and surfactants
- 1 January 2008
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 347 (1-2) , 45-53
Surface tension and rheology of aqueous dispersed systems containing a new hydrophobically modified polymer and surfactants
- 1 April 2006
- Published by Wiley in Biomedical Chromatography
- Vol. 20 (10) , 1024-1027
Determination of foscarnet (trisodium phosphonoformate) in pharmaceutical preparations by high‐performance liquid chromatography with ultraviolet detection
An isocratic high‐performance liquid chromatographic method with UV detection has been developed and validated for the quantitative determination of foscarnet in isoosmotic sodium chloride aqueous solution. The mobile phase consisted of mixture of methanol:water (30:70 v/v), containing 1 mm tetrahexylammonium hydrogen sulphate at pH 5.80. The analyte was separated on a reversed‐phase C18 column packed with 4 µm spherical particles of octadecylsilane. Hydrochlorothiazide was used as internal standard. UV detection at 232 nm allowed a quantification limit of 50 µg/mL. The assay was linear from 50 to 4000 µg/mL. The coefficient of variation was ≤2.52% for intra‐assay precision and ≤3.49% for inter‐assay precision. The deviation from the nominal value ranged from −0.57 to 0.47% for the same‐day accuracy and from −0.75 to 3.06% for day‐to‐day accuracy. Copyright © 2006 John Wiley & Sons, Ltd.
- 1 April 2006
- Published by Wiley in Biomedical Chromatography
- Vol. 20 (10) , 1024-1027
Determination of foscarnet (trisodium phosphonoformate) in pharmaceutical preparations by high‐performance liquid chromatography with ultraviolet detection
An isocratic high‐performance liquid chromatographic method with UV detection has been developed and validated for the quantitative determination of foscarnet in isoosmotic sodium chloride aqueous solution. The mobile phase consisted of mixture of methanol:water (30:70 v/v), containing 1 mm tetrahexylammonium hydrogen sulphate at pH 5.80. The analyte was separated on a reversed‐phase C18 column packed with 4 µm spherical particles of octadecylsilane. Hydrochlorothiazide was used as internal standard. UV detection at 232 nm allowed a quantification limit of 50 µg/mL. The assay was linear from 50 to 4000 µg/mL. The coefficient of variation was ≤2.52% for intra‐assay precision and ≤3.49% for inter‐assay precision. The deviation from the nominal value ranged from −0.57 to 0.47% for the same‐day accuracy and from −0.75 to 3.06% for day‐to‐day accuracy. Copyright © 2006 John Wiley & Sons, Ltd.
- 15 August 2005
- Vol. 39 (5) , 551-6
Therapeutic drug monitoring of efavirenz: trough levels cannot be estimated on the basis of earlier plasma determinations.
The few studies evaluating the relation between efavirenz (EFV) plasma levels and efficacy have only shown a weak association. They are based on population pharmacokinetics and/or estimation of trough levels from samples obtained at different time points, because this drug is usually taken at bedtime. We explore whether a limited sampling strategy could provide a good estimation of EFV trough levels and area under the curve (AUC). Fifty-nine 24-hour profiles from patients on 600 mg of EFV administered once daily were included for the analysis. Plasma drug concentrations were determined by a validated high-performance liquid chromatography assay. The relation between EFV plasma concentrations at C8, C12, and C16 and the corresponding C24 and AUC0-24 values were assessed in different index sets, and their predictive performances were evaluated in the validation sets. EFV plasma levels at C12 and C16 are precise predictors of AUC0-24 (<or=10% mean relative prediction errors). The estimation of C24 levels from EFV plasma concentrations at C8, C12, or C16 is not precise enough (18%-62% mean relative prediction errors), however, and the use of C12 and C16 in combination does not improve the accuracy of C24 prediction. No adequate substitute for collecting blood 24 hours after dosing emerged from this analysis, which might explain the weak association observed between EFV plasma levels and treatment outcomes in the studies available.
- 15 August 2005
- Vol. 39 (5) , 551-6
Therapeutic drug monitoring of efavirenz: trough levels cannot be estimated on the basis of earlier plasma determinations.
The few studies evaluating the relation between efavirenz (EFV) plasma levels and efficacy have only shown a weak association. They are based on population pharmacokinetics and/or estimation of trough levels from samples obtained at different time points, because this drug is usually taken at bedtime. We explore whether a limited sampling strategy could provide a good estimation of EFV trough levels and area under the curve (AUC). Fifty-nine 24-hour profiles from patients on 600 mg of EFV administered once daily were included for the analysis. Plasma drug concentrations were determined by a validated high-performance liquid chromatography assay. The relation between EFV plasma concentrations at C8, C12, and C16 and the corresponding C24 and AUC0-24 values were assessed in different index sets, and their predictive performances were evaluated in the validation sets. EFV plasma levels at C12 and C16 are precise predictors of AUC0-24 (<or=10% mean relative prediction errors). The estimation of C24 levels from EFV plasma concentrations at C8, C12, or C16 is not precise enough (18%-62% mean relative prediction errors), however, and the use of C12 and C16 in combination does not improve the accuracy of C24 prediction. No adequate substitute for collecting blood 24 hours after dosing emerged from this analysis, which might explain the weak association observed between EFV plasma levels and treatment outcomes in the studies available.